Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
The Journal of Biological Chemistry|January 22, 2013
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cellsSusan L Heatley, Gabriella Pietra, Jie Lin, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet Singh Majhail, James Douglas Rizzo, Stephanie Joi Lee, et al.
American Journal of Hematology|February 19, 2021
Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life dataMajdolen Istaiti, Shoshana Revel-Vilk, Michal Becker-Cohen, et al.
American Journal of Hematology|February 13, 2013
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher diseaseHadhami Ben Turkia, Derlis E Gonzalez, Norman W Barton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Molecular Genetics and Metabolism|August 30, 2017
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physiciansAtul Mehta, Nadia Belmatoug, Bruno Bembi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]Navneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Blood|March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trialMats Brune, Sylvie Castaigne, John Catalano, et al.
The New England Journal of Medicine|September 10, 2015
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal HemoglobinuriaRichard J Kelly, Britta Höchsmann, Jeff Szer, et al.
Blood Advances|September 2, 2018
Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studiesAlexander Röth, Scott T Rottinghaus, Anita Hill, et al.
Pageof 35